相似文献
1
Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia.
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3270-5. doi: 10.1073/pnas.052712399. Epub 2002 Feb 19.
2
Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-kappaB-dependent gene expression in primary cultured mouse glial cells.
J Biol Chem. 2004 Oct 8;279(41):42774-86. doi: 10.1074/jbc.M407923200. Epub 2004 Aug 9.
3
Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice.
EMBO J. 1999 Aug 16;18(16):4446-54. doi: 10.1093/emboj/18.16.4446.
4
Defective transcription factor activation for proinflammatory gene expression in poly(ADP-ribose) polymerase 1-deficient glia.
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5087-92. doi: 10.1073/pnas.0306895101. Epub 2004 Mar 23.
5
Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders.
J Neurochem. 2003 Apr;85(2):306-17. doi: 10.1046/j.1471-4159.2003.01684.x.
6
Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice.
J Clin Invest. 2004 Oct;114(8):1072-81. doi: 10.1172/JCI21854.
7
Activator protein-1 signalling pathway and apoptosis are modulated by poly(ADP-ribose) polymerase-1 in experimental colitis.
Immunology. 2004 Dec;113(4):509-17. doi: 10.1111/j.1365-2567.2004.01991.x.
8
Regulation of poly(ADP-ribose) polymerase-1 (PARP-1) gene expression through the post-translational modification of Sp1: a nuclear target protein of PARP-1.
BMC Mol Biol. 2007 Oct 25;8:96. doi: 10.1186/1471-2199-8-96.
9
Role of PARP on iNOS pathway during endotoxin-induced acute lung injury.
Intensive Care Med. 2004 Jul;30(7):1421-31. doi: 10.1007/s00134-004-2301-x. Epub 2004 Jun 10.
10
Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Circulation. 2007 May 8;115(18):2442-50. doi: 10.1161/CIRCULATIONAHA.106.668756. Epub 2007 Apr 16.
引用本文的文献
1
Recent Advances in Biomolecular Patho-Mechanistic Pathways behind the Development and Progression of Diabetic Neuropathy.
Biomedicines. 2024 Jun 23;12(7):1390. doi: 10.3390/biomedicines12071390.
2
CB2 Cannabinoid Receptor as a Potential Target in Myocardial Infarction: Exploration of Molecular Pathogenesis and Therapeutic Strategies.
Int J Mol Sci. 2024 Jan 30;25(3):1683. doi: 10.3390/ijms25031683.
3
Diabetic Neuropathy: An Overview of Molecular Pathways and Protective Mechanisms of Phytobioactives.
Endocr Metab Immune Disord Drug Targets. 2024;24(7):758-776. doi: 10.2174/0118715303266444231008143430.
4
NAD Homeostasis and NAD-Consuming Enzymes: Implications for Vascular Health.
Antioxidants (Basel). 2023 Feb 4;12(2):376. doi: 10.3390/antiox12020376.
5
Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes.
Life (Basel). 2022 Jul 19;12(7):1074. doi: 10.3390/life12071074.
6
Therapeutic Potential of Polyphenols in the Management of Diabetic Neuropathy.
Evid Based Complement Alternat Med. 2021 May 13;2021:9940169. doi: 10.1155/2021/9940169. eCollection 2021.
7
Minireview Exploring the Biological Cycle of Vitamin B3 and Its Influence on Oxidative Stress: Further Molecular and Clinical Aspects.
Molecules. 2020 Jul 22;25(15):3323. doi: 10.3390/molecules25153323.
8
A New Pathway Promotes Adaptation of Human Glioblastoma Cells to Glucose Starvation.
Cells. 2020 May 18;9(5):1249. doi: 10.3390/cells9051249.
9
The Multifactorial Role of PARP-1 in Tumor Microenvironment.
Cancers (Basel). 2020 Mar 20;12(3):739. doi: 10.3390/cancers12030739.
10
PKC, AKT and ERK1/2-Mediated Modulations of PARP1, NF-κB and PEA15 Activities Distinctly Regulate Regional Specific Astroglial Responses Following Status Epilepticus.
Front Mol Neurosci. 2019 Jul 24;12:180. doi: 10.3389/fnmol.2019.00180. eCollection 2019.
本文引用的文献
1
Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1.
Nat Cell Biol. 2001 Dec;3(12):1035-42. doi: 10.1038/ncb1201-1035.
2
The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function.
J Biol Chem. 2001 Dec 7;276(49):45588-97. doi: 10.1074/jbc.M106528200. Epub 2001 Oct 4.
3
The sequence-specific DNA binding of NF-kappa B is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1.
J Biol Chem. 2001 Dec 14;276(50):47664-70. doi: 10.1074/jbc.M104666200. Epub 2001 Sep 27.
4
Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
Cell Mol Biol Lett. 2001;6(2):117-40.
5
Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation.
J Mol Med (Berl). 2001 Aug;79(8):437-48. doi: 10.1007/s001090100236.
6
Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38.
Cell Signal. 2001 May;13(5):299-310. doi: 10.1016/s0898-6568(01)00148-6.
7
Poly(ADP-ribose) polymerase-1 in the nervous system.
Neurobiol Dis. 2000 Aug;7(4):225-39. doi: 10.1006/nbdi.2000.0324.
8
Myocardial postischemic injury is reduced by polyADPripose polymerase-1 gene disruption.
Mol Med. 2000 Apr;6(4):271-82.
9
Poly(ADP-ribose) polymerase is a B-MYB coactivator.
J Biol Chem. 2000 Apr 7;275(14):10692-6. doi: 10.1074/jbc.275.14.10692.
10
Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase.
Biochem J. 2000 Mar 15;346 Pt 3(Pt 3):641-9.
Zotero 插件